DT
PT
Subscribe To Print Edition About The Tribune Code Of Ethics Download App Advertise with us Classifieds
search-icon-img
search-icon-img
Advertisement
PREMIUM Explainers Defence Photo Gallery Cricket Simply Punjab Simply Haryana
Home / India / Clinical trials of TB vaccine for adults start in India

Clinical trials of TB vaccine for adults start in India

article_Author
Tribune News Service
Updated At : 12:31 PM Mar 25, 2024 IST
  • fb
  • twitter
  • whatsapp
  • whatsapp
featured-img featured-img
Advertisement

New Delhi: Bharat Biotech has begun the clinical trials for tuberculosis (TB) vaccine MTBVAC on adults in India. Developed by Spanish biopharmaceutical company Biofabri, the MTBVAC is the first vaccine against TB derived from a human source. TNS

Advertisement

Left stomps ABVP’s hopes, wins all JNUSU posts

new delhi: The United Left panel effected a clean sweep in the Jawaharlal Nehru University Students’ Union election, defeating its nearest rival the RSS-affiliated ABVP on Sunday. Dhananjay won the president’s post by securing 2,598 votes.

Advertisement

Advertisement
Tags :
Advertisement
Advertisement
Advertisement

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is run by a trust comprising five eminent persons as trustees.

The Tribune, the largest selling English daily in North India, publishes news and views without any bias or prejudice of any kind. Restraint and moderation, rather than agitational language and partisanship, are the hallmarks of the newspaper. It is an independent newspaper in the real sense of the term.

The Tribune has two sister publications, Punjabi Tribune (in Punjabi) and Dainik Tribune (in Hindi).

Remembering Sardar Dyal Singh Majithia

Copyright © The Tribune Trust, 2024
Designed and developed by : sortd
tlbr_img1 Classifieds tlbr_img2 Videos tlbr_img3 Premium tlbr_img4 E-Paper tlbr_img5 Shorts